Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 139th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
CRNX	CRINETICS PHARMACEUTICALS INC	$2.83B	-30.90%	-27.90%	-21.70%	-39.90%	0.08	23.05	100.00%	-28,720.70%	-28,720.69%
KPTI	KARYOPHARM THERAPEUTICS INC	$41.66M	N/A	-39.60%	-53.97%	-15.50%	-1.88	1.70	95.90%	-52.60%	-26.81%
CLNN	CLENE INC	$25.76M	N/A	-109.20%	-207.30%	-149.90%	-4.09	1.57	79.50%	-11,520.50%	-10,332.16%
VYGR	VOYAGER THERAPEUTICS INC	$174.45M	-19.90%	-15.10%	-18.74%	-22.30%	0.31	5.56	100.00%	-81.30%	-80.42%
SLDB	SOLID BIOSCIENCES INC	$197.61M	-70.40%	-56.70%	-78.51%	-92.40%	0.38	5.20	N/A	N/A	N/A
KYMR	KYMERA THERAPEUTICS INC	$1.69B	-28.70%	-24.20%	-24.57%	-26.40%	0.17	7.53	100.00%	-475.60%	-475.04%
NMRA	NEUMORA THERAPEUTICS INC	$104.80M	-69.00%	-64.00%	-84.86%	-145.20%	0.10	10.51	N/A	N/A	N/A
CDTX	CIDARA THERAPEUTICS INC	$212.94M	-173.30%	-112.60%	-102.77%	705.80%	0.32	4.25	100.00%	-13,319.80%	-13,319.76%
BHVN	BIOHAVEN LTD	$2.08B	-237.70%	-159.20%	-183.49%	-336.80%	0.45	3.49	N/A	N/A	N/A
ANNX	ANNEXON INC	$160.18M	-44.30%	-38.40%	-43.25%	-53.40%	0.19	10.37	N/A	N/A	N/A
UBX	UNITY BIOTECHNOLOGY INC	$16.36M	-161.50%	-52.70%	-91.51%	-48.20%	4.80	2.62	N/A	N/A	N/A
RVMD	REVOLUTION MEDICINES INC	$6.83B	-33.50%	-29.90%	-25.09%	-37.80%	0.13	14.20	N/A	N/A	N/A
APGE	APOGEE THERAPEUTICS INC	$1.97B	-24.10%	-23.10%	-25.11%	-36.00%	0.05	18.55	N/A	N/A	N/A
CRVO	CERVOMED INC	$85.29M	-46.50%	-42.50%	-41.56%	-60.90%	0.10	11.11	100.00%	-167.30%	-167.29%
VERA	VERA THERAPEUTICS INC	$1.36B	-39.30%	-33.10%	-22.93%	-32.90%	0.14	25.67	N/A	N/A	N/A
RAPT	RAPT THERAPEUTICS INC	$104.29M	-98.90%	-82.20%	-67.65%	-193.30%	0.27	4.87	N/A	N/A	N/A
ALMS	ALUMIS INC	$272.04M	N/A	-98.40%	-101.43%	-222.30%	0.31	6.01	N/A	N/A	N/A
COGT	COGENT BIOSCIENCES INC	$497.52M	-74.90%	-63.30%	-94.00%	-101.80%	0.28	5.32	N/A	N/A	N/A
HOWL	WEREWOLF THERAPEUTICS INC	$41.20M	-73.40%	-47.10%	-58.93%	-137.60%	0.73	7.45	100.00%	-3,740.80%	-3,493.85%
INBX	INHIBRX BIOSCIENCES INC	$166.04M	1,243.20%	710.30%	1,214.73%	4,559.00%	0.35	3.94	100.00%	843,786.00%	850,532.50%
CHRS	COHERUS BIOSCIENCES INC	$129.80M	-29.50%	4.80%	33.62%	18.10%	-4.40	1.21	56.00%	10.70%	20.85%
BLRX	BIOLINERX LTD	$12.86M	-75.30%	-17.70%	-0.43%	-1.70%	1.89	1.76	68.00%	-31.90%	-0.35%
IMVT	IMMUNOVANT INC	$2.57B	-77.90%	-69.80%	-108.38%	1,944.10%	0.19	6.04	N/A	N/A	N/A
ALDX	ALDEYRA THERAPEUTICS INC	$130.76M	-60.70%	-45.70%	-62.70%	-126.70%	0.47	5.60	N/A	N/A	N/A
CBUS	CIBUS INC	$57.37M	-134.30%	-55.70%	-65.77%	-88.60%	2.74	0.85	100.00%	-5,898.40%	-5,095.47%
ACHV	ACHIEVE LIFE SCIENCES INC	$69.02M	-110.60%	-72.00%	-117.83%	-129.20%	0.85	5.46	N/A	N/A	N/A
ADVM	ADVERUM BIOTECHNOLOGIES INC	$61.21M	-92.70%	-56.00%	-83.42%	-77.10%	1.54	5.73	100.00%	-13,092.70%	-13,092.70%
GUTS	FRACTYL HEALTH INC	$59.68M	-120.60%	-51.70%	-77.79%	-78.00%	2.80	3.63	46.20%	-75,732.30%	-73,864.52%
CELC	CELCUITY INC	$387.48M	-77.70%	-44.80%	-47.56%	-35.70%	1.12	7.71	N/A	N/A	N/A
IMUX	IMMUNIC INC	$88.35M	-194.40%	-135.70%	-537.67%	641.20%	1.22	1.77	N/A	N/A	N/A
CTNM	CONTINEUM THERAPEUTICS INC	$119.53M	-30.70%	-21.80%	-20.83%	-28.20%	0.08	20.69	N/A	N/A	N/A
INZY	INOZYME PHARMA INC	$59.04M	-115.30%	-68.10%	-108.04%	-61.90%	1.13	3.56	N/A	N/A	N/A
DYN	DYNE THERAPEUTICS INC	$924.20M	-49.00%	-45.20%	-48.91%	-138.60%	0.10	15.60	N/A	N/A	N/A
ETNB	89BIO INC	$884.66M	-81.40%	-70.00%	-81.59%	-101.40%	0.19	13.19	N/A	N/A	N/A
CDXS	CODEXIS INC	$174.79M	-92.90%	-45.10%	-43.75%	-44.00%	1.23	4.18	72.60%	-110.00%	-92.42%
VKTX	VIKING THERAPEUTICS INC	$2.69B	-12.10%	-11.70%	-12.48%	-13.20%	0.03	33.09	N/A	N/A	N/A
PHVS	PHARVARIS NV	$761.31M	-42.70%	-40.20%	N/A	-1,555.60%	0.09	N/A	N/A	N/A	N/A
MRNA	MODERNA INC	$9.54B	-30.10%	-22.80%	-30.22%	-29.10%	0.30	3.67	54.80%	-110.00%	-111.46%
DTIL	PRECISION BIOSCIENCES INC	$52.62M	12.30%	4.50%	7.37%	27.30%	1.42	6.34	100.00%	10.40%	13.03%
GALT	GALECTIN THERAPEUTICS INC	$87.19M	N/A	-188.80%	231.70%	-54.00%	-1.15	0.49	N/A	N/A	N/A
KYTX	KYVERNA THERAPEUTICS INC	$80.38M	-40.30%	-36.50%	-47.01%	-66.50%	0.14	8.61	N/A	N/A	N/A
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	$2.45B	-24.30%	-23.00%	-26.56%	-69.40%	0.06	21.11	N/A	N/A	N/A
OBIO	ORCHESTRA BIOMED HOLDINGS INC	$109.19M	-135.20%	-79.60%	-101.76%	-138.90%	1.31	4.27	92.30%	-2,313.30%	-2,313.27%
ANVS	ANNOVIS BIO INC	$23.77M	-873.00%	-239.00%	-244.81%	1,333.50%	0.50	3.59	N/A	N/A	N/A
DWTX	DOGWOOD THERAPEUTICS INC	$8.16M	N/A	-49.70%	-13.65%	-366.00%	-2.97	5.21	N/A	N/A	N/A
ABVX	ABIVAX SA	$405.43M	-149.00%	-66.20%	-143.17%	-301.30%	4.06	1.82	100.00%	-1,415.70%	-1,279.23%
LRMR	LARIMAR THERAPEUTICS INC	$122.29M	-39.70%	-35.60%	-45.83%	-50.70%	0.17	8.02	N/A	N/A	N/A
IMRX	IMMUNEERING CORP	$45.58M	-100.00%	-85.30%	-135.00%	-588.50%	0.27	5.28	N/A	N/A	N/A
TPST	TEMPEST THERAPEUTICS INC	$331.12M	-245.60%	-103.40%	-148.62%	-244.40%	1.17	2.21	N/A	N/A	N/A
SNDX	SYNDAX PHARMACEUTICALS INC	$992.72M	-80.70%	-58.70%	-50.51%	-71.50%	1.52	5.82	96.50%	-1,346.10%	-1,325.29%
CERO	CERO THERAPEUTICS HOLDINGS INC	$3.32M	N/A	-144.50%	646.80%	206.50%	-4.28	0.50	N/A	N/A	N/A
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	$450.17M	-38.20%	-11.20%	-10.41%	-12.80%	1.33	7.53	41.80%	-55.90%	-38.20%
CDT	CONDUIT PHARMACEUTICALS INC	$4.13M	N/A	-462.10%	248.87%	3,029.00%	-1.62	0.25	N/A	N/A	N/A
CLDX	CELLDEX THERAPEUTICS INC	$1.21B	-19.80%	-19.00%	-20.97%	-21.90%	0.06	18.92	100.00%	-2,248.80%	-2,248.76%
RXRX	RECURSION PHARMACEUTICALS INC	$2.21B	-72.90%	-52.90%	-36.86%	-220.30%	0.40	3.81	23.10%	-788.00%	-789.93%
EYPT	EYEPOINT PHARMACEUTICALS INC	$390.04M	-50.70%	-38.10%	-35.40%	-77.00%	0.24	7.82	91.40%	-302.40%	-302.19%
ABOS	ACUMEN PHARMACEUTICALS INC	$54.58M	-45.20%	-37.40%	-46.48%	-41.00%	0.31	6.46	N/A	N/A	N/A
CABA	CABALETTA BIO INC	$55.82M	-62.00%	-54.70%	-72.88%	-385.60%	0.22	6.15	N/A	N/A	N/A
JSPR	JASPER THERAPEUTICS INC	$59.64M	-79.40%	-68.00%	-110.22%	2,901.20%	0.30	4.98	N/A	N/A	N/A
PHAR	PHARMING GROUP NV	$550.37M	-5.40%	-2.80%	-2.60%	-2.60%	0.81	3.77	88.10%	-4.00%	-2.86%
RNAZ	TRANSCODE THERAPEUTICS INC	$6.37M	-1,212.00%	-287.60%	-369.87%	2,147.20%	-4.61	2.56	N/A	N/A	N/A
RLMD	RELMADA THERAPEUTICS INC	$9.63M	-147.60%	-124.50%	-225.13%	-153.90%	0.29	4.45	N/A	N/A	N/A
RNXT	RENOVORX INC	$37.28M	-156.10%	-100.90%	-148.14%	973.30%	0.81	4.10	100.00%	-20,497.70%	-21,390.70%
RENB	RENOVARO INC	$56.03M	-111.70%	-88.90%	-123.85%	956.80%	0.24	0.09	N/A	N/A	N/A
PTN	PALATIN TECHNOLOGIES INC	$4.29M	N/A	-360.90%	513.23%	348.10%	-1.68	0.38	100.00%	-7,700.60%	-7,696.53%
PMN	PROMIS NEUROSCIENCES INC	$20.76M	51.60%	23.00%	17.11%	-1,875.60%	0.15	8.53	N/A	N/A	N/A
SPRB	SPRUCE BIOSCIENCES INC	$5.03M	-102.90%	-77.60%	-175.98%	905.10%	0.57	2.90	100.00%	-1,079.90%	-1,073.69%
QLGN	QUALIGEN THERAPEUTICS INC	$2.39M	N/A	-539.90%	318.37%	357.80%	-2.08	0.52	N/A	N/A	N/A
PTIX	PROTAGENIC THERAPEUTICS INC	$1.81M	-474.60%	-294.30%	-545.36%	-340,335.30%	0.93	2.00	N/A	N/A	N/A
PRTC	PURETECH HEALTH PLC	$431.85M	N/A	N/A	N/A	N/A	0.87	3.68	N/A	N/A	N/A
PMCB	PHARMACYTE BIOTECH INC	$8.17M	30.30%	21.00%	47.50%	98.90%	0.09	14.20	N/A	N/A	N/A
XFOR	X4 PHARMACEUTICALS INC	$33.17M	-84.50%	-23.10%	-24.98%	-31.10%	5.61	3.41	68.80%	-1,464.60%	-1,109.58%
PASG	PASSAGE BIO INC	$20.51M	-78.60%	-54.00%	-77.99%	-66.20%	0.67	4.07	N/A	N/A	N/A
OGEN	ORAGENICS INC	$3.76M	-620.10%	-327.20%	4,973.50%	-11,624.30%	-7.95	0.87	N/A	N/A	N/A
RNTX	REIN THERAPEUTICS INC	$37.39M	-73.60%	-67.10%	-114.15%	1,657.40%	0.14	2.38	N/A	N/A	N/A
PLRZ	POLYRIZON LTD	$1.49M	-60.60%	-50.60%	-24.63%	-2,578.20%	0.05	10.17	N/A	N/A	N/A
VXRT	VAXART INC	$78.41M	-101.80%	-50.00%	-88.32%	-103.50%	1.82	0.75	100.00%	-233.30%	-232.36%
CSCI	COSCIENS BIOPHARMA INC	$8.88M	-84.60%	-38.10%	-54.21%	-162.80%	1.67	3.32	49.30%	-159.70%	-157.46%
NRXS	NEURAXIS INC	$11.55M	N/A	-356.70%	-347.09%	594.70%	1.30	1.75	86.50%	-314.70%	-300.35%
NLSP	NLS PHARMACEUTICS LTD	$1.44M	N/A	-380.80%	97.52%	147.30%	-1.13	0.16	N/A	N/A	N/A
TNFA	TNF PHARMACEUTICALS INC	$1.85M	-296.80%	-125.80%	-158.69%	-495.30%	0.69	1.40	N/A	N/A	N/A
NERV	MINERVA NEUROSCIENCES INC	$11.19M	-4.50%	3.30%	4.19%	-51.90%	-2.45	7.85	N/A	N/A	N/A
NCNA	NUCANA PLC	$4.89M	-313.60%	-96.00%	-367.57%	353.70%	1.48	1.42	N/A	N/A	N/A
PLUR	PLURI INC	$28.20M	N/A	-55.90%	-78.26%	-37.80%	-4.21	5.04	69.90%	-2,929.20%	-3,049.56%
PMVP	PMV PHARMACEUTICALS INC	$52.97M	-29.30%	-26.40%	-42.28%	-43.40%	0.09	12.22	N/A	N/A	N/A
MTVA	METAVIA INC	$6.40M	-221.20%	-131.10%	-345.37%	359.40%	1.05	1.94	N/A	N/A	N/A
ATHE	ALTERITY THERAPEUTICS LTD	$37.24M	-155.80%	-120.90%	-252.18%	-452.10%	0.36	3.84	100.00%	-531.30%	-530.10%
MRSN	MERSANA THERAPEUTICS INC	$44.24M	-990.20%	-40.00%	-78.95%	-103.80%	-16.21	2.19	100.00%	-170.90%	-160.26%
PCSA	PROCESSA PHARMACEUTICALS INC	$1.16M	-233.20%	-184.30%	-698.44%	-2,099.00%	0.90	1.22	N/A	N/A	N/A
NAUT	NAUTILUS BIOTECHNOLOGY INC	$95.62M	-30.90%	-26.60%	-30.10%	-26.30%	0.16	17.40	N/A	N/A	N/A
MTNB	MATINAS BIOPHARMA HOLDINGS INC	$3.05M	-170.10%	-125.70%	-243.92%	-181.10%	0.67	3.01	N/A	N/A	N/A
SNSE	SENSEI BIOTHERAPEUTICS INC	$10.23M	-61.90%	-53.60%	-75.33%	-70.20%	0.18	7.70	N/A	N/A	N/A
MDCX	MEDICUS PHARMA LTD	$53.66M	-357.90%	-211.10%	-334.69%	1,263.90%	0.80	2.33	N/A	N/A	N/A
MCRB	SERES THERAPEUTICS INC	$64.51M	-0.50%	0.10%	0.14%	0.10%	9.14	0.94	N/A	N/A	N/A
NXTC	NEXTCURE INC	$10.11M	-68.40%	-57.20%	-78.07%	-80.20%	0.24	7.50	N/A	N/A	N/A
MLEC	MOOLEC SCIENCE SA	$27.04M	-150.90%	-26.60%	-25.84%	-22.10%	10.22	1.48	-8.20%	-105.70%	-82.22%
SPRC	SCISPARC LTD	$1.01M	103.20%	55.80%	70.70%	215.00%	0.26	1.86	69.00%	325.40%	351.35%
LYRA	LYRA THERAPEUTICS INC	$5.67M	-265.60%	-98.00%	-173.87%	-109.90%	4.72	3.41	100.00%	-6,090.90%	-6,088.40%
MEIP	MEI PHARMA INC	$13.10M	-116.70%	-92.80%	-172.94%	-131.20%	0.10	10.66	N/A	N/A	N/A
LPTX	LEAP THERAPEUTICS INC	$14.98M	-137.50%	-106.90%	-191.08%	542.40%	0.40	3.41	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Apr 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Protalix Biotherapeutics (NYSEMKT:PLX)

Protalix Biotherapeutics (NYSEMKT:PLX) is the #1 top biotech stock out of 664 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Protalix Biotherapeutics (NYSEMKT:PLX) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: C.

Protalix Biotherapeutics (NYSEMKT:PLX) has a Due Diligence Score of 23, which is -1 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates PLX as a "A".

PLX passed 7 out of 33 due diligence checks and has weak fundamentals. Protalix Biotherapeutics has seen its stock return 126.96% over the past year, overperforming other biotech stocks by 206 percentage points.

Protalix Biotherapeutics has an average 1 year price target of $15.00, an upside of 474.71% from Protalix Biotherapeutics's current stock price of $2.61.

Protalix Biotherapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Protalix Biotherapeutics, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #2 top biotech stock out of 664 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 57, which is 33 points higher than the biotech industry average of 24.

AUPH passed 19 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 57.84% over the past year, overperforming other biotech stocks by 136 percentage points.

3. Rigel Pharmaceuticals (NASDAQ:RIGL)

Rigel Pharmaceuticals (NASDAQ:RIGL) is the #3 top biotech stock out of 664 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Rigel Pharmaceuticals (NASDAQ:RIGL) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: D, Financials: B, and AI: C.

Rigel Pharmaceuticals (NASDAQ:RIGL) has a Due Diligence Score of 52, which is 28 points higher than the biotech industry average of 24.

RIGL passed 17 out of 33 due diligence checks and has strong fundamentals. Rigel Pharmaceuticals has seen its stock return 51.8% over the past year, overperforming other biotech stocks by 130 percentage points.

Rigel Pharmaceuticals has an average 1 year price target of $36.80, an upside of 118.4% from Rigel Pharmaceuticals's current stock price of $16.85.

Rigel Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Rigel Pharmaceuticals, 20% have issued a Strong Buy rating, 20% have issued a Buy, 60% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 8.02%, which is 6 percentage points higher than the biotech industry average of 2.16%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.78%, which is 1 percentage points higher than the biotech industry average of 2.16%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% ten times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.5% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.32%, which is -1 percentage points lower than the biotech industry average of 2.16%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 43.8% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.44% in the last day, and up 7.32% over the last week. Channel Therapeutics was the among the top gainers in the biotechnology industry, gaining 46.61% yesterday.

Channel Therapeutics shares are trading higher after the company announced that it will combine with Ligand Subsidiary Pelthos Therapeutics to create a pain medicines focused entity.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has dropped -44.68% in the past year. It has overperformed other stocks in the biotech industry by 34 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -2.5% in the past year. It has overperformed other stocks in the biotech industry by 76 percentage points.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has dropped -4.03% in the past year. It has overperformed other stocks in the biotech industry by 75 percentage points.

Are biotech stocks a good buy now?

55.56% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 119.43% over the next year.

1.96% of biotech stocks have a Zen Rating of A (Strong Buy), 4.36% of biotech stocks are rated B (Buy), 40.74% are rated C (Hold), 36.38% are rated D (Sell), and 16.56% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -177.72x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.